- Home
- Results news
- Dharti Proteins
- Q2 FY27 results
Dharti Proteins Q2 FY27 results: net profit ₹3.37 crore
Dharti Proteins Limited reported standalone revenue of ₹2.85 crore, EBITDA of ₹1.27 crore and a net profit of ₹3.37 crore for Q2 FY27. The quarter ended with a basic EPS of ₹67.45, compared with a net loss of ₹0.14 crore in Q1 FY27 and a net loss of ₹0.0 crore in Q2 FY26.
Key points
- Standalone Q2 FY27 revenue was ₹2.85 crore, against ₹0 crore in Q2 FY26 and Q1 FY27.
- EBITDA was ₹1.27 crore, with an EBITDA margin of 44.5%, and turned to profit from a net loss of ₹0.14 crore in Q1 FY27.
- Q2 FY27 net profit was ₹3.37 crore and basic EPS was ₹67.45.
- H1 FY27 revenue was ₹2.85 crore, total income was ₹6.0 crore and net profit was ₹3.23 crore.
- The board recommended a 1:1 bonus issue for public shareholders, excluding promoters and the promoter group, subject to shareholder approval.
How did Dharti Proteins perform in Q2 FY27?
Dharti Proteins reported standalone revenue of ₹2.85 crore, EBITDA of ₹1.27 crore and an EBITDA margin of 44.5% in Q2 FY27. Against Q2 FY26, revenue was higher by ₹2.85 crore and EBITDA moved from a net loss of ₹0.01 crore to profit, a difference of ₹1.28 crore. Against Q1 FY27, revenue was higher by ₹2.85 crore and EBITDA improved by ₹1.41 crore, moving from a net loss of ₹0.14 crore to profit.
The company reported a net profit of ₹3.37 crore and basic EPS of ₹67.45 for Q2 FY27. Net profit was higher by ₹3.37 crore than in Q2 FY26 and by ₹3.51 crore than in Q1 FY27, when it reported a net loss of ₹0.14 crore. EPS increased by ₹67.45 from Q2 FY26 and by ₹70.31 from Q1 FY27. The results were on a standalone basis, and the filing did not provide consolidated figures for the quarter.
| ₹ crore | Q2 FY27 | Q1 FY27 | Q2 FY26 | YoY | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 2.85 | 0 | 0 | ||
| Other income | 3.15 | 0 | 0 | ||
| Total expenses | 1.58 | 0.14 | 0.01 | +15700.0% | +1028.6% |
| EBITDA | 1.27 | −0.14 | −0.01 | turned to profit | turned to profit |
| EBITDA margin | 44.5% | ||||
| Profit before tax | 4.41 | −0.14 | 0 | turned to profit | |
| Tax | 1.04 | 0 | 0 | ||
| Net profit | 3.37 | −0.14 | 0 | turned to profit | |
| EPS (₹) | 67.45 | −2.86 | 0.00 | turned to profit |
EBITDA here is revenue from operations less operating costs (total expenses excluding finance costs and depreciation): before other income and exceptional items. Growth is shown only when both figures are positive. Source: Company's results filing (XBRL).
What changed in Dharti Proteins' costs and profit?
Other income was ₹3.15 crore in Q2 FY27, against ₹0 crore in both Q2 FY26 and Q1 FY27, representing increases of ₹3.15 crore. The auditor’s report stated that the company received a waiver of unsecured loan amounting to Rs.314.50 lakhs from its Managing Director under the approved resolution plan and recognised the amount as other income during the quarter and period.
Total expenses were ₹1.58 crore, up ₹1.57 crore from ₹0.01 crore in Q2 FY26 and up ₹1.44 crore from ₹0.14 crore in Q1 FY27. Other expenses were ₹0.15 crore, compared with ₹0.01 crore a year ago and ₹0.12 crore in the previous quarter; employee cost was ₹0.03 crore, while cost of materials, finance costs and depreciation were unchanged at ₹0 crore. There was no exceptional item. Tax was ₹1.04 crore, compared with ₹0 crore in both comparison quarters.
| ₹ crore | Q2 FY27 | Q2 FY26 | Change | Change % |
|---|---|---|---|---|
| Cost of materials | 0 | 0 | 0 | |
| Employee cost | 0.03 | 0 | +0.03 | |
| Finance costs | 0 | 0 | 0 | |
| Depreciation | 0 | 0 | 0 | |
| Other expenses | 0.15 | 0.01 | +0.14 | +1400.0% |
| Total expenses | 1.58 | 0.01 | +1.57 | +15700.0% |
| Other income | 3.15 | 0 | +3.15 | |
| Tax | 1.04 | 0 | +1.04 |
Source: Company's results filing (XBRL).
How did the first half of FY27 go?
In H1 FY27, Dharti Proteins reported revenue of ₹2.85 crore, total income of ₹6.0 crore, PBT of ₹4.27 crore and net profit of ₹3.23 crore, with basic EPS of ₹64.59. In H1 FY26, revenue was ₹0 crore, total income was ₹0.02 crore, PBT and net profit were each a loss of ₹0.05 crore, and basic EPS was -₹0.05.
Total income increased by ₹5.98 crore in the first half, while PBT moved to profit from a loss of ₹0.05 crore, a difference of ₹4.32 crore. Net profit moved to ₹3.23 crore from a loss of ₹0.05 crore, a difference of ₹3.28 crore, and EPS increased by ₹64.64.
| ₹ crore | H1 FY27 | H1 FY26 | Change |
|---|---|---|---|
| Revenue from operations | 2.85 | 0 | |
| Profit before tax | 4.27 | −0.05 | turned to profit |
| Net profit | 3.23 | −0.05 | turned to profit |
| EPS (₹) | 64.59 | −0.05 |
Source: Company's results filing (XBRL).
What do the balance sheet and cash flow show?
At 30 September 2026, total assets were ₹3.49 crore, compared with ₹0.72 crore on 31 March 2026. Total equity was ₹0.59 crore against negative equity of ₹2.64 crore, while borrowings fell to ₹0.4 crore from ₹3.34 crore and cash rose to ₹0.1 crore from ₹0.03 crore. Trade receivables were ₹2.85 crore and trade payables were ₹1.43 crore; inventories were unchanged at ₹0 crore.
For H1 FY27, operating cash flow was -₹0.14 crore, compared with -₹3.87 crore in H1 FY26. Investing cash flow was ₹0 crore against ₹2.61 crore, financing cash flow was ₹0.2 crore against ₹0 crore, and capital expenditure was ₹0 crore in both periods.
| ₹ crore | As of 30 September 2026 | As of 31 March 2026 |
|---|---|---|
| Total assets | 3.49 | 0.72 |
| Total equity | 0.59 | −2.64 |
| Borrowings | 0.40 | 3.34 |
| Cash and equivalents | 0.10 | 0.03 |
| Inventories | 0 | 0 |
| Trade receivables | 2.85 | 0 |
Source: Company's results filing (XBRL).
| ₹ crore | H1 FY27 | H1 FY26 |
|---|---|---|
| Cash from operations | −0.14 | −3.87 |
| Cash from investing | 0 | 2.61 |
| Cash from financing | 0.20 | 0 |
| Capital expenditure | 0 | 0 |
Source: Company's results filing (XBRL).
How has Dharti Proteins done over the last 7 quarters?
The quarterly trend changed in Q2 FY27 after a period of negligible revenue. Revenue reached ₹2.85 crore in the September 2026 quarter, while net profit rose to ₹3.37 crore from a loss of ₹0.14 crore in Q1 FY27. The EBITDA margin was 44.5% in Q2 FY27; the available quarterly data do not provide comparable margins for the earlier quarters.
Net profit had declined to a loss of ₹0.46 crore in Q4 FY26 before improving to a loss of ₹0.14 crore in Q1 FY27 and then turning positive in Q2 FY27. Revenue was ₹0 crore through Q1 FY27 before reaching ₹2.85 crore in the latest quarter, indicating a shift from sustained losses to reported profit.
What else did the company announce?
On 13 October 2026, the board approved the audited standalone financial results for the quarter and half year ended 30 September 2026, along with the interim audit report and declaration of an unmodified report. It recommended one bonus equity share of Rs. 10/- each for every one fully paid-up equity share held by public shareholders, excluding promoters and the promoter group, as on the record date. The proposal is intended to meet minimum public shareholding requirements and requires shareholder approval.
The board also approved the appointment of M/S J M Patel & Bros, Chartered Accountants, as tax auditor for FY 2026-27 and initiated a change of registrar and transfer agent from System Support Services to Bigshare Services Private Limited. It called an extraordinary general meeting for 6 November 2026 to seek shareholders’ approval for the bonus issue, appointed Bigshare as remote e-voting agency and appointed M/s. Dharti Patel & Associates as scrutiniser.
How did Dharti Proteins shares react?
The results were filed after market hours on 13 October 2026. From the pre-results close of ₹66.92, the stock was up 5.0% on the reaction day. By the next day’s close, it was up 10.2% from that pre-results close, and by the fifth session it was up 34.0%.
Over the same closes, the Nifty Microcap 250 rose 0.7% on the reaction day, fell 1.0% by the next day and fell 5.5% by the fifth session. The available data do not provide an industry median reaction or earlier results-day moves for comparison.
| After the filing | Stock |
|---|---|
| Reaction day | +5.0% |
| Next day | +10.2% |
| 5 days | +34.0% |
Minutes are measured from the price when the filing appeared; days from the previous close. Source: MarketPing price-reaction measurement.
Quick answers
What was Dharti Proteins' revenue in Q2 FY27?
Revenue from operations was ₹2.85 crore, against ₹0 crore in Q2 FY26 (standalone).
Did Dharti Proteins make a profit in Q2 FY27?
Yes. Net profit was ₹3.37 crore, against a net profit of ₹0 crore in Q2 FY26.
What was Dharti Proteins' EPS in Q2 FY27?
Basic earnings per share were ₹67.45, against ₹0.00 in Q2 FY26.
How did Dharti Proteins shares react to the Q2 FY27 results?
On the reaction day the stock moved +5.0% from the previous close.
When did Dharti Proteins announce its Q2 FY27 results?
On 13 October 2026, in a filing to the BSE.
Sources
- Board Meeting Intimation for Meeting Of Board Of Directors To Be Held On Tuesday, 13Th October, 2026 (BSE, 8 October 2026) · PDF
- Board Meeting Outcome for For Meeting Of Board Of Directors Held On October 13, 2026 (BSE, 13 October 2026) · PDF
- Revised Outcome For Meeting Of Board Of Directors Held On October 13, 2026 (BSE, 13 October 2026) · PDF
- Results - Financial Results For September 30, 2026 (BSE, 13 October 2026) · PDF
How this was written: every figure in the tables and charts is calculated from the company’s filed results (XBRL) and MarketPing’s price measurements. The text is drafted with AI from those figures and the filings, and a checker removes any sentence carrying a number it cannot trace to them. How we write these.
This is information, not investment advice. MarketPing does not recommend buying or selling any security.